Allied Market Research
Loading...
0
New
New
2021
Enteral Collagen Peptide Protein Market

Enteral Collagen Peptide Protein Market by Form (Liquid & Powder), Age Group (Adults (above 18) & Pediatrics (below 18), and End User (Hospital & Clinics, Nursing Home, and Homecare): Global Opportunity Analysis and Industry Forecast, 2021–2030

A13675
Pages: 199
Sep 2021 | 246 Views
   
Author(s) : Sushant Terdale , Onkar Sumant
Tables: 114
Charts: 26
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Enteral Collagen Peptide Protein Market

Request Now !

The global enteral collagen peptide protein market was valued at $14,586 thousand in 2020, and is projected to reach $25,811 thousand by 2030, registering a CAGR of 7.2% from 2021-2030. Collagen peptide protein is a protein derived from animal collagen. Enteral collagen peptide protein is a rich source of healthy nutrients that is prescribed to patients who are unable to consume sufficient nutrients orally, but whose gastrointestinal function is in a satisfactory condition for digestion and absorption. This process is deployed when a patient is unable to eat due to some illness, has swallowing difficulties, or has underwent surgery that may interfere with the normal eating process. In this process, collagen peptides protein is administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes.

Rise in the prevalence of chronic illness such osteoarthritis and cardiovascular diseases and increase in applications of collagen peptide protein in the healthcare sector are the major factors driving the growth of the global enteral collagen peptide protein market. Furthermore, increase in geriatric population along with favorable government initiates to promote healthy diet among population are expected to provide lucrative opportunities for existing players and new entrants. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth. Conversely, high growth potential in untapped emerging economies is expected to provide new avenues for the expansion of the global market during the forecast period.

Enteral-Collagen-Peptide-Protein-Market-2021-2030

Get more information on this report : Request Sample Pages

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a negative impact on enteral collagen peptide protein market, owing to decline in meat consumption, especially marine and bovine products, across the globe. This factor has directly impacted the production of collagen peptides, as fish and beef wastes are major raw materials for collagen products. In addition, business collaborations and partnership opportunities for enteral collagen peptide protein are negatively affected by COVID-19 outbreak, which led to decline in the enteral collagen peptide protein products production. Thus, the enteral collagen peptide protein market has been negatively impacted due to the current global health crisis

Enteral Collagen Peptide Protein Market Segmentation  

The global enteral collagen peptide protein market is segmented into form, age group, end user, and region. On the basis of form, the enteral collagen peptide protein market is bifurcated into powder and liquid. By age group, it is classified into adults (above 18) and pediatrics (below 18). Depending on end user, it is fragmented into hospitals & clinics, homecare, and nursing home. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

Segment review 

On the basis of form, the liquid segment is the major revenue contributor, and is projected to grow significantly during the forecast period, owing to increase in the demand and consumption of enteral supplements that come in the form of liquid, due to increase in availability of liquid enteral collagen peptide protein products and rise in health concerns among consumers.

Enteral Collagen Peptide Protein Market
By Form

Your browser does not support the canvas element.

Liquid segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

On the basis of age group, the adult (above 18 years) segment was the major revenue contributor, and is projected to grow significantly during the forecast period. This is attributed to higher number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. Furthermore, increase in geriatric population that requires enteral collagen peptide protein and has difficulty in swallowing is expected to contribute toward the market growth.

Enteral Collagen Peptide Protein Market
By Age Group

Your browser does not support the canvas element.

Age Group Segment hold the dominant position and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By end user, the homecare segment is the major shareholder in the enteral collagen protein peptide market, owing to increase in number of patients adopting enteral collagen peptide protein products administration at home and increase in demand for home care enteral collagen peptide protein treatment. 

Enteral Collagen Peptide Protein Market
By End User

Your browser does not support the canvas element.

Home Care Segment hold the dominant position and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific enteral collagen peptide protein market  

Asia-Pacific presents lucrative opportunities for key players operating in the enteral collagen peptide protein market, owing to increase in geriatric population, R&D investments in developments of collagen peptide protein products for various chronic diseases, supportive government initiatives directed toward the reduction of the malnutrition deficiency, and significant surge in demand for advanced healthcare facilities.

Enteral Collagen Peptide Protein Market
By Country

2030
Europe 
North America
Asia-pacific
Lamea

Asia Pacific exhibit the highest CAGR of 9.2 % during 2021-2030

Get more information on this report : Request Sample Pages

Moreover, rise in number of people suffering from arthritis disease and surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share are expected to drive growth of the enteral collagen peptide protein market in the region.

The key players profiled in this report include Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medline Industries, Inc, Global Health Products, Inc., OP2 labs, LLC, fresenius Kabi AG, Gelita AG, and Weishardt Holding SA.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the enteral collagen peptide protein market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers enteral collagen peptide protein market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global enteral collagen peptide protein market growth.

Key Market Segments

By Form

  • Powder
  • Liquid

By Age Group

  • Adults (Above 18)
  • Pediatrics (Below 18)

By End User

  • Hospitals & Clinics
  • Homecare
  • Nursing Home

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market share analysis, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of chronic disorders
3.5.1.2.Surge in geriatric population
3.5.1.3.Rise in number of malnutrition cases

3.5.2.Restraint

3.5.2.1.Poor demand in underdeveloped countries

3.5.3.Opportunity

3.5.3.1.High growth potential in emerging markets

3.5.4.Impact analysis

3.6.COVID-19 impact analysis on enteral collagen peptide protein market

CHAPTER 4:ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM

4.1.Overview

4.1.1.Market size and forecast

4.2.Powder

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Liquid

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP

5.1.Overview

5.1.1.Market size and forecast

5.2.Adults (above18)

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Pediatric (below 18 years)

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

CHAPTER 6:ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & clinics

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Homecare

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Nursing home

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by form
7.2.4.Market size and forecast, by age group
7.2.5.Market size and forecast, by end user
7.2.6.U.S.

7.2.6.1.U.S. market size and forecast, by form
7.2.6.2.U.S. market size and forecast, by age group
7.2.6.3.U.S. market size and forecast, by end user

7.2.7.Canada

7.2.7.1.Canada market size and forecast, by Form
7.2.7.2.Canada market size and forecast, by age group
7.2.7.3.Canada market size and forecast, by end user

7.2.8.Mexico

7.2.8.1.Mexico market size and forecast, by form
7.2.8.2.Mexico market size and forecast, by age group
7.2.8.3.Mexico market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by form
7.3.4.Market size and forecast, by age group
7.3.5.Market size and forecast, by end user
7.3.6.Germany

7.3.6.1.Germany market size and forecast, by form
7.3.6.2.Germany market size and forecast, by age group
7.3.6.3.Germany market size and forecast, by end user

7.3.7.France

7.3.7.1.France market size and forecast, by form
7.3.7.2.France market size and forecast, by age group
7.3.7.3.France market size and forecast, by end user

7.3.8.UK

7.3.8.1.UK market size and forecast, by form
7.3.8.2.UK market size and forecast, by age group
7.3.8.3.UK market size and forecast, by end user

7.3.9.Italy

7.3.9.1.Italy market size and forecast, by form
7.3.9.2.Italy market size and forecast, by age group
7.3.9.3.Italy market size and forecast, by end user

7.3.10.Spain

7.3.10.1.Spain market size and forecast, by form
7.3.10.2.Spain market size and forecast, by age group
7.3.10.3.Spain market size and forecast, by end user

7.3.11.Rest of Europe

7.3.11.1.Rest of Europe market size and forecast, by form
7.3.11.2.Rest of Europe market size and forecast, by age group
7.3.11.3.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by form
7.4.4.Market size and forecast, by age group
7.4.5.Market size and forecast, by end user
7.4.6.Japan

7.4.6.1.Japan market size and forecast, by form
7.4.6.2.Japan market size and forecast, by age group
7.4.6.3.Japan market size and forecast, by end user

7.4.7.China

7.4.7.1.China market size and forecast, by form
7.4.7.2.China market size and forecast, by age group
7.4.7.3.China market size and forecast, by end user

7.4.8.Australia

7.4.8.1.Australia market size and forecast, by form
7.4.8.2.Australia market size and forecast, by age group
7.4.8.3.Australia market size and forecast, by end user

7.4.9.India

7.4.9.1.India market size and forecast, by form
7.4.9.2.India market size and forecast, by age group
7.4.9.3.India market size and forecast, by end user

7.4.10.South Korea

7.4.10.1.South Korea market size and forecast, by form
7.4.10.2.South Korea market size and forecast, by age group
7.4.10.3.South Korea market size and forecast, by end user

7.4.11.Rest of Asia-Pacific

7.4.11.1.Rest of Asia-Pacific market size and forecast, by form
7.4.11.2.Rest of Asia-Pacific market size and forecast, by age group
7.4.11.3.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by form
7.5.4.Market size and forecast, by age group
7.5.5.Market size and forecast, by end user
7.5.6.Brazil

7.5.6.1.Brazil market size and forecast, by form
7.5.6.2.Brazil market size and forecast, by age group
7.5.6.3.Brazil market size and forecast, by end user

7.5.7.Saudi Arabia

7.5.7.1.Saudi Arabia market size and forecast, by form
7.5.7.2.Saudi Arabia market size and forecast, by age group
7.5.7.3.Saudi Arabia market size and forecast, by end user

7.5.8.South Africa

7.5.8.1.South Africa market size and forecast, by form
7.5.8.2.South Africa market size and forecast, by age group
7.5.8.3.South Africa market size and forecast, by end user

7.5.9.Rest of LAMEA

7.5.9.1.Rest of LAMEA market size and forecast, by form
7.5.9.2.Rest of LAMEA market size and forecast, by age group
7.5.9.3.Rest of LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance

8.2.DANONE S.A. (NUTRICIA)

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.DERMARITE INDUSTRIES LLC

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.FRESENIUS KABI AG

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.GLOBAL HEALTH PRODUCTS, INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.MEDLINE INDUSTRIES, INC.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.MEDTRITION INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio

8.8.OP2 LABS LLC

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio

8.9.GELITA AG

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.WEISHARDT HOLDING SA

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio

LIST OF TABLES

TABLE 01.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 02.POWDER ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY REGION, 2020–2030 ($THOUSAND)
TABLE 03.LIQUID ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY REGION, 2020–2030 ($THOUSAND)
TABLE 04.GLOBAL ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 05.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR ADULTS (ABOVE18), BY REGION, 2020-2030 ($THOUSAND)
TABLE 06.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR PEDIATRIC (BELOW 18 YEARS), BY REGION, 2020–2030 ($THOUSAND)
TABLE 07.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 08.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR HOSPITAL & CLINICS, BY REGION, 2020–2030 ($THOUSAND)
TABLE 09.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR HOMECARE, BY REGION, 2020–2030 ($THOUSAND)
TABLE 10.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR NURSING HOMES, BY REGION, 2020–2030 ($THOUSAND)
TABLE 11.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY REGION, 2020–2030 ($THOUSAND)
TABLE 12.NORTH AMERICA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 13.NORTH AMERICA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 14.NORTH AMERICA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 15.NORTH AMERICA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 16.U.S. ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 17.U.S. ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 18.U.S. ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 19.CANADA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 20.CANADA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 21.CANADA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 22.MEXICO ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 23.MEXICO ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 24.MEXICO ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 25.EUROPE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 26.EUROPE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 27.EUROPE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 28.EUROPE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 29.GERMANY ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($MILLION)
TABLE 30.GERMANY ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 31.GERMANY ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 32.FRANCE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 33.FRANCE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 34.FRANCE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 35.UK ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 36.UK ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 37.UK ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 38.ITALY ENTERAL COLLAGEN PEPTIDEP ROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 39.ITALY ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 40.ITALY ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 41.SPAIN ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 42.SPAIN ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 43.SPAIN ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 44.REST OF EUROPE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 45.REST OF EUROPE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 46.REST OF EUROPE ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 47.ASIA-PACIFIC ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 48.ASIA-PACIFIC ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 49.ASIA-PACIFIC ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2039 ($THOUSAND)
TABLE 50.ASIA-PACIFIC ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 51.JAPAN ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 52.JAPAN ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 53.JAPAN ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 54.CHINA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 55.CHINA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 56.CHINA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 57.AUSTRALIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 58.AUSTRALIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 59.AUSTRALIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 60.INDIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 61.INDIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 62.INDIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 63.SOUTH KOREA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 64.SOUTH KOREA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 65.SOUTH KOREA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 66.REST OF ASIA-PACIFIC ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 67.REST OF ASIA-PACIFIC ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 68.REST OF ASIA-PACIFIC ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 69.LAMEA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY COUNTRY, 2020–2030 ($THOUSAND)
TABLE 70.LAMEA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 71.LAMEA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 72.LAMEA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 73.BRAZIL ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 74.BRAZIL ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 75.BRAZIL ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 76.SAUDI ARABIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 77.SAUDI ARABIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 78.SAUDI ARABIA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 79.SOUTH AFRICA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET,BY FORM, 2020–2030 ($THOUSAND)
TABLE 80.SOUTH AFRICA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 81.SOUTH AFRICA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 82.REST OF LAMEA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY FORM, 2020–2030 ($THOUSAND)
TABLE 83.REST OF LAMEA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY AGE GROUP, 2020–2030 ($THOUSAND)
TABLE 84.REST OF LAMEA ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY END USER, 2020–2030 ($THOUSAND)
TABLE 85.ABBOTT: COMPANY SNAPSHOT
TABLE 86.ABBOTT: OPERATING SEGMENTS
TABLE 87.ABBOTT: PRODUCT PORTFOLIO
TABLE 88.DANONE: COMPANY SNAPSHOT
TABLE 89.DANONE: OPERATING SEGMENTS
TABLE 90.DANONE: PRODUCT PORTFOLIO
TABLE 91.DERMARITE: COMPANY SNAPSHOT
TABLE 92.DERMARITE: OERATING SEGMENT
TABLE 93.DERMARITE: PRODUCT PORTFOLIO
TABLE 94.FRESENIUS KABI AG: COMPANY SNAPSHOT
TABLE 95.FRESENIUS KABI AG: OPERATING SEGMENTS
TABLE 96.FRESENIUS KABI AG: PRODUCT PORTFOLIO
TABLE 97.GLOBAL HEALTH: COMPANY SNAPSHOT
TABLE 98.GLOBAL HEALTH: OPERATING SEGMENTS
TABLE 99.GLOBAL HEALTH: PRODUCT PORTFOLIO
TABLE 100.MEDLINE: COMPANY SNAPSHOT
TABLE 101.MEDLINE: OPERATING SEGMENTS
TABLE 102.MEDLINE: PRODUCT PORTFOLIO
TABLE 103.MEDTRITION: COMPANY SNAPSHOT
TABLE 104.MEDTRITION: OPERATING SEGMENTS
TABLE 105.MEDTRITION: PRODUCT PORTFOLIO
TABLE 106.OP2 LABS: COMPANY SNAPSHOT
TABLE 107.OP2 LABS: OERATING SEGMENT
TABLE 108.OP2 LABS: PRODUCT PORTFOLIO
TABLE 109.GELITA: COMPANY SNAPSHOT
TABLE 110.GELITA: OPERATING SEGMENTS
TABLE 111.GELITA: PRODUCT PORTFOLIO
TABLE 112.WEISHARDT: COMPANY SNAPSHOT
TABLE 113.WEISHARDT: OERATING SEGMENT
TABLE 114.WEISHARDT: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.TOP PLAYER POSITIONING, 2020
FIGURE 09.IMPACT ANALYSIS
FIGURE 10.COMPARATIVE SAHRE ANALYSIS OF POWDER ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 11.COMPARATIVE SAHRE ANALYSIS OF LIQUID ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET, BY COUNTRY,  2020 & 2030 (%)
FIGURE 12.COMPARATIVE SAHRE ANALYSIS OF ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR ADULTS (ABOVE18), BY COUNTRY, 2020 & 2030 (%)
FIGURE 13.COMPARATIVE SAHRE ANALYSIS OF ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR PEDIATRIC (BELOW 18 YEARS), BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.COMPARATIVE SAHRE ANALYSIS OF ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR HOSPITAL & CLINICS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 15.COMPARATIVE SAHRE ANALYSIS OF ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR HOMECARE,  BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE SAHRE ANALYSIS OF ENTERAL COLLAGEN PEPTIDE PROTEIN MARKET FOR NURSING HOMES,  BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 18.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 19.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 20.DANONE: NET SALES, 2018–2020 ($MILLION)
FIGURE 21.DANONE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22.DANONE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23.FRESENIUS KABI AG: REVENUE, 2018–2020 ($MILLION)
FIGURE 24.FRESENIUS KABI AG: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.FRESENIUS KABI AG: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26.GELITA: NET SALES, 2018–2020 ($MILLION)

 
 

Enteral collagen peptide protein is recommended for patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. In enteral feeding system, nutrition or medications are directly administered in the stomach or intestine.

Factors such as rise in sale of enteral collagen peptide protein products, consumer focus on protein-rich diets, and rise in use of collagen peptide protein in the healthcare industry due to their high protein content drive the growth of market. In addition, increase in investment in R&D activities to develop innovative products and rise in number of malnutrition cases drives the growth of the market. Moreover, surge in geriatric population and favorable government initiatives to promote healthy diet among population. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth during the forecast period.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Enteral Collagen Peptide Protein Market is $ 25,811 Thousand in 2020

A. The forecast period in the report is from 2021 to 2030

A. The market value of Enteral Collagen Peptide Protein in 2020 was 14,586 Thousand

A. The base year for the report is 2020

A. Yes, Enteral Collagen Peptide Protein Market companies are profiled in the report

A. The top companies that hold the market share in Enteral Collagen Peptide Protein Market are are Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medlin Industries

A. No, there is no value chain analysis provided in the Enteral Collagen Peptide Protein Market report

A. The key trends in the Enteral Collagen Peptide Protein Market are increase in number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis and increase in demand for home care enteral collagen peptide protein treatment

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Enteral Collagen Peptide Protein Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers